Foreign body associated infections  by unknown
34 Journal of Clinical Microbiology and Infection, Volume 3 Supplement 2 
Molecular methods for the diagnosis of 
infectious diseases 
(ESCMID European Study Group on 
Molecular Diagnostics) 
I S1541 Broad-Spectlum PCR for the Detection of 
Uncultured Bacteria: Problems and Promises 
M. Altwegg. Department of Medical Microbiology, University of Zurich, 
Switzerland 
Amplification techniques have had an enormous impact on the dng- 
nosis of infections associated with bacteria that are difficult to culture 
on a routine basis for various reasons (previous antibiotic therapy, no 
suMv-A upon prolonged transport, requirement for cell cultures). In 
contrast to cultures, however, specific amplification assays can only 
be used if one or a few particular organisms need to be looked for. 
The concept of broad-spectrum PCR amp-g part of the 16s 
rFWA genes of all (most) bacteria by using primers directed against 
conserved regions of these molecules followed by direct sequenc- 
ing (i.e. without subcloning) of the amplified hgment or by using 
specific probes for identification provides a promising approach for 
the detection of any bacteria present in a particular chical material 
including as yet unknown organism. We have successfidy used this 
approach for detecting bacteria in culture-negative specimens (Eo- 
pheryma whippelii in a case of spondylodiscitis, BorreZia burgdorferi in 
s y n o d  specimens of patienu with reactive arthritis, T whippelii and 
other orgdnisms in heart valves of patients with endocarditis, etc.). 
This technique, however, is h t e d  to monobacterial infections and 
normally sterile specimens. In addition, it is usually less sensitive than 
species-specific assays because relatively large hgments need to be 
amplified to provide sufKcient sequence information for identifica- 
tion, and it is prone to reagent contamination (bacterial DNA in 
water, enzymes, etc.). 
m] Molecular Detection of Antibiotic Resistance 
M.R. Visser. NL 
No abstract available. 
Clinical Relevance of Quantitative PCR 
C. BrCchot. F 
No abstract available. 
The Clinician and Molecular Diagnostics: A 
Critical View 
ED. Goebel. D 
No abstract available. 
=/ The Cost-Effectiveness of Gene-Amplification 
Methods in Screening for Chlamydia 
trachomatis 
J.-M. Schulenburg, K. Obermann. Institute for Insurance Economicr, 
University of Hannover, Germany 
Objectives: Chlamydia trachomafic (CT) infection is characterised 
by a low clinical manifestation rate and subsequent chronic inflam- 
mation. Gene-amplification methods show a marked improvement 
in sensitivity to previously available kits but at a higher price. A 
cost-effectiveness analysis fivm the health insurance perspective was 
undertaken to assess the costs and benefits h m  using LCWPCR in 
comparison to other tests in screening women in Germany. 
Methods: A decision-tree was developed to assess the cost of an 
unrecognised CT-infection. We included all outcomes of infected 
female patients as well as those of their partner and newborn chil- 
dren. We used a Markov Chain model c h c a l  development of the 
unrecognised infection as well as the impact of screening. The tran- 
sition probabhties are based on literature review and expert inter- 
views. A detailed cost analysis for CT-related complications was un- 
dertaken and expert opinion was used to assess the cost for treating 
male patients and chddren. Average test kit sensitivities are based on 
a literature review, praalence data were taken h m  recent findings 
by Petersen et al., Freiburg. A sensitivity analysis was carried out 
regarding the test kit sensitivities, the transition probabilities and the 
Results: Any screening strategy employed with any test kit re- 
sulted in substantial cost savings compared to no screening. Using 
the more expensive but more sensitive LCFUPCR yielded additional 
savings between 20 and 207 million DM. The result are robust as 
shown by the sensitivity analysis. 
Conclusion: Screening for CT-infection in the female popula- 
tion is a cost-effective way to prevent chronic inflammation and 
subsequent sequelae due to this infection. LCFUF'CR-methods are 
most e6cient here. 
cost. 
Foreign body associated infections 
I s159 I Pathogenesis of device related infections 
FA. Waldvogel. Univmity Hospital, Geneva, Switzerland 
Implanted biomateriak are increasingly used in medxine, recon- 
structive surgery and chronic inland outpatient therapies. Dysfunc- 
tions, tissue intolerance and mfection are the 3 most dreaded compli- 
cations of indwelhg devices. Besides deficient antimicrobial mech- 
anisms such as neutrophil dysfunction, increased adherence to bio- 
materlak has been recognized as an important initiating step of in- 
fection: orthopedic, intravascular, and subcutaneous imphts  of var- 
ious chemical composition are rapidly coated by host proteins, in- 
cluding fibrinogen, fibronectin, thrombospondm. vitronectin. Fre- 
quently encountered pathogens such as S. nureus posses well char- 
acterized surface adhesions, such as clumping factor or fibronectin 
adhesion proteins, which interact specifically with known sequences 
on fibrinogen and fibronectin. Site specific mutations, complemen- 
tation experiments with doned genes, and lnhibition studies with 
truncated adhesions or antibodies confirm the importance of these 
factors in in vitro and in vim model. 
I S160 I Genetic and Biochemical Characterization of 
Staphylococcus epidennidis Biofilm 
Accumulation 
D. Mack. Insfihrte ofMed. Microbiology and Immunoloa, University 
Hospital Eppendod Hamburg, Germany 
The primary attachment to polymer surfaces followed by accumu- 
lation in multi-layered cell clusters leads to hiofilm-production of 
S. epidemidis, which is thought to contribute to virulence in for- 
eign-body infections. Using an absorbed antiserum raised against 
biofilm producing S. epidmidis 1457 an antigen specifically ex- 
pressed by biofilm producing S. epidennidis strains was detected. By 
transposon mutagenesis using Tn917 mutants of biofilm producing 
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S. ep idmid i s  9142 were isolated, which were completely biofilm 
negative. Linkage of transposon insertions and phenotypic changes 
was proven by phage transduction. Primary attachment of the mu- 
tants to polystyrene was unchanged compared to wildtype, however, 
formation of large cell clusters by the mutants was completely abol- 
ished. The mutants did not produce detectable amounts of the spe- 
cific antigen proving its function in intercellular adhesion of S. epider- 
midis cells essential for b i o f h  accumulation. F'urfication and struc- 
tural analysis of the antigen revealed a polysaccharide mainly com- 
posed of B-1,6-linked 2-amino-2-deoxy-D-glucopyranosid residues. 
80-85% of the sugar residues are N-acetylated whereas the rest 
is non-N-acetylated and positively charged. Due to its function 
we refer to the polysaccharide as polysaccharide intercellular ad- 
hesin (PIA). There was a statistical significant association between 
biohlm-production and PIA expression in 179 clinical S. epidermidis 
isolates. A linear association between the amount of PIA produced as 
detected by ELISA-inhibition and the amount of biofilm produced 
was established for 49 S. epidermidis strains representing a continuum 
h m  biofilm-negative to strongly biofh-producing (r = 0.81, p < 
0,001). Apparently PIA is important for b i o f h  accumulation of the 
majority of clinical S. epidermidis isolates. 
dents suffering b m  staphylococcal infection associated with sta- 
ble orthopedic devices. The patients were assigned to receive ei- 
ther ciprofloxacin/rifampin or ciprofloxacin/placebo. Twenty-four 
patients fully completed the trial. The cure rate was 12/12 in the 
former and 7/12 in the latter group (p = 0.019). Nine patients 
dropped out, mainly due to adverse events. Seven of 9 drop-out pa- 
tients were subsequently treated with rifampin-combinations, partly 
in reduced dose. Six of them were cured, among them 5 patients 
without removal of the device. 
Conclusion: Orthopedic device-related infections due to ri- 
fampin and ciprofloxacin susceptible staphylococci can be cured 
without removal of the device, given the implant is stable, an initial 
dkbridement is performed, and the patient tolerates long-term (3-6 
months) therapy. 
State-of-the-Art Lectures 
I S161 1 Anti-lnfectiie Coatings Can Decrease the Risk of 
Infection Associated with Foreign Bodies 
R. Sherertz. &an Gray School $Medicine, Winston-Salem, NC 
27157, USA 
In the last 20 years there have been increasingly frequent attempts 
to use anti-infective coatings to prevent foreign body infections. 
In animal models (mouse, rat, rabbit) using staphylococci as in- 
fecting organisms efficacious anti-mfective coatings have included 
penicillin G, dicloxach, clindamycin, fusidic acid, chlorhexidine 
(Ch), silver sulfadiazine (AgS), minocycline (M), rifampin (R), and 
benzalkonium chloride as well as certain combinations AgS/Ch, 
M/R, M/EDTA. Ineffective coatings in animal models include 
ciprofloxacin, cefotaxime, Ag and TDMAC. In vivo half-lifes of 
successful coatings range from t 6  h to 2 4  days. In vitm zones of 
inhibition z15 mm by a modhed Kirby-Bauer method have been 
predictive of anti-infective coating efficacy both in animal models 
and in clinical trials. M/R and AgS/Ch coatings have both been 
demonstrated to have efficacy in randomized c h c a l  trials. Ulti- 
mately the optimal coahng must have broad spectrum antimicrobial 
activity and possibly other qualities as well, such as anti-inflammatory 
or anti-thrombotic capabhties. Additional studies are necessary to 
understand the optimal use of anti-mfective coatings and whether 
large scale use will lead to problems with resistance. 
I S162 I Antibiotic Therapy of Staphylococcal 
W. Zimmerli. Division In+ct. Diseases, University Hospitals, Basel, 
Swi t zdand  
Device-related infections persist without treatment and rarely re- 
spond to antimicrobial therapy without removal of the implant. 
This may be due to resistance of adherent bacteria to phagocyto- 
sis and to most antibiotics. A special problem are orthopedic de- 
vice-related infections because these implants cannot easily be re- 
moved. Observational studies showed that despite prolonged (4-6 
weeks) iv-treatment with betalactam antibiotics, the failure rate with 
retention of the device is between 32% and 82%. In contrast, treat- 
ment with quinolone/rifampin combinations showed lower fail- 
ure rates (18-38%) in 2 uncontrolled studies. We therefore con- 
ducted a double blind, randomized clinical trial involving 33 pa- 
Device-Related Infections 
I s163 I Antibiotic Resistance: Quo vadis? 
E Baquero. E 
No abstract available. 
1 S 164 1 Challenges for Future Vaccines 
PH. Lambert. C H  
No abstract available. 
Advances in herpes virus infections 
I S165 I Prevention of HSV transmission: chemotherapy 
or vaccination, what seems approachable 
L. Corcy. University $ Washington G. Fred Hutchinson Cancer Research 
C e n t q  Seattle, WA, USA 
Prevention of HSV transmission is the major scientific question to 
be solved in HSV immunobiology. Tramtionally t h i s  approach has 
best been developed by vaccination. However, several aspects about 
herpes simplex virus lnfection make vaccination a potentially &I- 
cult goal. This includes the very short time between viral inoculation 
on mucosal surfaces and sequestration of the virus within the pro- 
tected site of the neuron. Recent studies with very potent subunit 
vaccines have given less than optimal prevention. Another approach 
to prevention is the use of chemotherapeutic approaches to prevent 
HSV reactivation at mucosal sites. Recent studies have indicated that 
HSV reactivates much more frequently than previously appreciated. 
In immuno-competent persons, HSV DNA is found on mucosal 
surfaces on 25-30% of days. All available data suggest that such HSV 
DNA is infectious and associated with replicating virions in epithe- 
lial cells. These data indicate that a chemotherapeutic approach in 
which daily suppression of viral replication by an antiviral may be 
a useful approach for preventing the transmission of HSV infection. 
This may have important implications with respect to management 
of HSV in pregnancy, the interaction between HSV and HIV in HIV 
infected persons as well as attempting to reduce the transmission of 
HSV between sexual partners. These issues will be discussed. 
